Six of ten evaluable myelofibrosis patients who received GB monotherapy for at least six months experienced a -grade reduction in collagen fibrosis of the bone marrow validating LOXL as a clinical fibrosis targetBOSTON Dec GLOBE NEWSWIRE -- Galecto Inc NASDAQ GLTO a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer today announced positive...
Globe News Wire
ST LOUIS Dec GLOBE NEWSWIRE -- Stifel Financial Corp NYSE SF today reported selected operating results for November in an effort to provide timely information to investors on certain key performance metrics Due to the limited nature of this data a consistent correlation to earnings should not be assumed Ronald J Kruszewski Chairman and Chief Executive Officer said In November...
REDWOOD CITY Calif Dec GLOBE NEWSWIRE -- Seer Inc Nasdaq SEER a leading life sciences company commercializing a disruptive new platform for proteomics today announced that the company will be participating in the upcoming J P Morgan nd Annual Health Care Conference in San Francisco CA Seer s management is scheduled to present and participate in a Q amp A...
ATHENS Greece Dec GLOBE NEWSWIRE -- Capital Product Partners L P the Partnership CPLP or we us NASDAQ CPLP today announced the closing of the umbrella agreement the Umbrella Agreement entered into on November with Capital Maritime amp Trading Corp Capital Maritime and Capital GP L L C the General Partner providing for the acquisition of newbuild liquefied natural gas...